Catalyst Wire Dossier Catalyst Wire Dossier

Dovprela Tablets 200 mg

· Viatris Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dovprela Tablets 200 mg, covering 2024-06-24 to 2024-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance

See pricing